B3GALNT2 antibody (Middle Region)
Quick Overview for B3GALNT2 antibody (Middle Region) (ABIN2783624)
Target
See all B3GALNT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Sequence
- GKWQELEYPS PAYPAFACGS GYVISKDIVK WLASNSGRLK TYQGEDVSMG
-
Predicted Reactivity
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 93%
-
Characteristics
- This is a rabbit polyclonal antibody against B3GALNT2. It was validated on Western Blot using a cell lysate as a positive control.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human B3GALNT2
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 500 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- B3GALNT2 (beta-1,3-N-Acetylgalactosaminyl Transferase 2 (B3GALNT2))
-
Alternative Name
- B3GALNT2
-
Background
-
B3GALNT2 is the beta-1,3-N-acetylgalactosaminyltransferase active in synthesizing a unique carbohydrate structure, GalNAc-beta-1-3GlcNAc, on N- and O-glycans. B3GALNT2 has no galactose nor galactosaminyl transferase activity toward any acceptor substrate.
Alias Symbols: B3GalNAc-T2, MGC39558
Protein Interaction Partner: FBXO6, UBC,
Protein Size: 500 -
Molecular Weight
- 57 kDa
-
Gene ID
- 148789
-
NCBI Accession
- NM_152490, NP_689703
-
UniProt
- Q8NCR0
Target
-